US · RMD
ResMed Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- San Diego, CA 92123
- Website
- resmed.com
Price · as of 2025-06-30
$205.02
Market cap 37.41B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $230.05 | +12.21% |
| Intrinsic Value(DCF) | $153.91 | -24.93% |
| Graham-Dodd Method(GD) | $35.86 | -82.51% |
| Graham Formula(GF) | $167.12 | -18.49% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $23.98 | $54.43 | $19.80 | $17.25 | $31.75 |
| 2012 | $32.92 | $59.37 | $15.04 | $18.00 | $30.91 |
| 2013 | $41.62 | $51.32 | $19.80 | $9.89 | $39.25 |
| 2014 | $45.81 | $56.57 | $9.82 | $7.58 | $25.91 |
| 2015 | $45.14 | $54.30 | $6.10 | $5.19 | $39.65 |
| 2016 | $58.93 | $57.68 | $9.27 | $0.00 | $43.51 |
| 2017 | $73.35 | $67.08 | $7.88 | $0.00 | $48.41 |
| 2018 | $104.48 | $78.64 | $30.29 | $0.00 | $45.88 |
| 2019 | $132.63 | $91.94 | $47.33 | $0.00 | $53.81 |
| 2020 | $165.62 | $114.08 | $48.67 | $2.35 | $90.22 |
| 2021 | $284.12 | $164.82 | $41.09 | $0.00 | $52.16 |
| 2022 | $228.54 | $144.22 | $42.56 | $11.24 | $104.64 |
| 2023 | $144.49 | $116.54 | $62.06 | $13.45 | $155.02 |
| 2024 | $241.62 | $175.67 | $60.52 | $19.67 | $129.53 |
| 2025 | $275.75 | $230.05 | $80.56 | $35.86 | $167.12 |
AI valuation
Our deep-learning model estimates ResMed Inc.'s (RMD) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $230.05
- Current price
- $205.02
- AI upside
- +12.21%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$153.91
-24.93% upside
Graham-Dodd
$35.86
-82.51% upside
Graham Formula
$167.12
-18.49% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| RMD | ResMed Inc. | $205.02 | 37.41B | +12% | -25% | -83% | -18% | 28.88 | 6.78 | 7.86 | 20.96 | 77.17 | 16.47 | 59.36% | 32.75% | 27.22% | 25.86% | 25.33% | 18.62% | 0.14 | 133.66 | 3.44 | 2.16 | -0.19 | 3743.00% | 984.00% | 2918.00% | 4.11% | 1.72 | 29.91% | 0.77% | 22.20% | 3.96% | 23.79 | 24.13 | 7.79 | 13.72 |
| A | Agilent Technologies, Inc… | $121.38 | 34.41B | -21% | -48% | -87% | -44% | 96.67 | 6.22 | 6.04 | 23.72 | 3059.02 | 23.01 | 52.43% | 21.29% | 18.75% | 6.87% | 16.33% | 3.53% | 0.50 | 13.21 | 1.96 | 1.40 | 0.85 | 316.00% | 673.00% | -1610.00% | 2.75% | 0.66 | 14.01% | 0.67% | 65.00% | 3.31% | 29.43 | 37.78 | 6.26 | 5.50 |
| ALC | Alcon Inc. | $87.18 | 42.49B | -32% | -61% | -65% | -71% | 42.77 | 1.90 | 4.03 | 19.38 | — | 11.11 | 55.24% | 13.08% | 9.42% | 4.50% | 4.55% | 3.17% | 0.24 | — | 2.12 | 1.16 | 1.58 | -341.00% | 494.00% | 2281.00% | 4.12% | 0.74 | 6.84% | 0.40% | 16.90% | 2.12% | 33.49 | 26.36 | 4.38 | 3.24 |
| BDX | Becton, Dickinson and Com… | $176.48 | 63.94B | +10% | -66% | — | -47% | 25.90 | 1.71 | 1.99 | 12.47 | — | -4.09 | 45.44% | 11.80% | 7.68% | 6.54% | 5.17% | 2.98% | 0.76 | 4.21 | 1.11 | 0.46 | 3.70 | -51.00% | 823.00% | -1309.00% | 6.14% | 0.41 | 6.01% | 2.75% | 71.30% | 8.27% | 23.97 | 23.14 | 2.83 | 1.86 |
| CAH | Cardinal Health, Inc. | $229.23 | 53.94B | -51% | +121% | — | -82% | 22.84 | -12.89 | 0.16 | 13.30 | 26.27 | -2.40 | 3.67% | 1.02% | 0.70% | -52.35% | -7229.54% | 3.19% | -3.36 | 10.58 | 0.94 | 0.44 | 1.76 | 8696.00% | -187.00% | -4309.00% | 5.16% | 0.06 | -7872.34% | 1.38% | 31.50% | 3.51% | 18.16 | 22.33 | 0.19 | 4.68 |
| GEHC | GE HealthCare Technologie… | $84.27 | 38.41B | +5% | -50% | -83% | -31% | 16.99 | 3.53 | 1.77 | 11.12 | 351.11 | -8.63 | 39.99% | 13.39% | 10.10% | 22.88% | 13.96% | 6.15% | 0.96 | 6.14 | 1.18 | 0.93 | 1.45 | 484.00% | 484.00% | -284.00% | 4.12% | 0.22 | 9.78% | 0.17% | 3.00% | 3.44% | 15.24 | 27.95 | 2.04 | 1.89 |
| HLN | Haleon plc | $11.07 | 49.3B | +256% | -54% | — | -81% | 22.30 | 2.22 | 3.37 | 15.73 | 178.37 | -3.96 | 64.77% | 22.44% | 15.11% | 10.01% | 7.93% | 4.88% | 0.52 | 7.28 | 0.92 | 0.70 | 2.62 | 1250.00% | -396.00% | -391.00% | 5.42% | 0.46 | 8.27% | 1.65% | 36.70% | 5.15% | 18.02 | 22.14 | 4.04 | 3.11 |
| HUM | Humana Inc. | $190.54 | 22.92B | -18% | +504% | -67% | -8% | 18.99 | 1.28 | 0.17 | 5.17 | — | 2.83 | 14.54% | 1.12% | 0.92% | 6.98% | 6.79% | 2.49% | 0.70 | 2.30 | 2.00 | 1.42 | 2.81 | -140.00% | 1006.00% | -8432.00% | 1.66% | 0.06 | 2.12% | 1.91% | 36.20% | 5.92% | 10.34 | 40.07 | 0.12 | 4.42 |
| INSM | Insmed Incorporated | $149.33 | 31.85B | -50% | +3,425% | — | — | -24.48 | 42.30 | 51.55 | -26.12 | -162.35 | 61.87 | 79.41% | -194.04% | -210.54% | -249.28% | -969.45% | -59.53% | 1.04 | -14.04 | 3.83 | 3.35 | -0.22 | 1508.00% | 6673.00% | 3709.00% | -3.10% | -1.99 | -797.14% | 0.00% | 0.00% | 1.60% | -26.00 | -31.62 | 50.46 | 8.06 |
| IQV | IQVIA Holdings Inc. | $178.81 | 30.45B | -2% | -53% | — | -39% | 22.01 | 4.61 | 1.84 | 12.70 | 471.04 | -1.99 | 26.28% | 14.02% | 8.34% | 21.65% | 9.92% | 4.79% | 2.49 | 3.14 | 0.75 | 0.67 | 4.10 | 467.00% | 587.00% | -298.00% | 6.85% | 0.32 | 10.54% | 0.00% | 0.00% | 4.15% | 19.23 | 21.45 | 2.70 | 1.83 |
| MTD | Mettler-Toledo Internatio… | $1,366.69 | 27.92B | -28% | -53% | -87% | -63% | 31.42 | -1155.46 | 6.78 | 23.96 | 851.91 | -26.22 | 57.52% | 27.78% | 21.59% | -1154.87% | 44.16% | 25.00% | -99.14 | 16.32 | 1.14 | 0.71 | 1.84 | 369.00% | 398.00% | -183.00% | 3.11% | 0.80 | 40.43% | 0.00% | 0.00% | 2.93% | 26.45 | 34.86 | 7.35 | 10.00 |
About ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
- CEO
- Michael J. Farrell
- Employees
- 9.98K
- Beta
- 0.88
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($153.91 ÷ $205.02) − 1 = -24.93% (DCF, example).